10:39 AM EST - BB1 Acquisition Corp. : And PlantEXT Ltd. announced that following more than three years of dedicated research in the laboratory of Prof. Hinanit Koltai, Agricultural Research Organization, PlantEXT and the State of Israel's ARO, have successfully refined earlier discoveries to develop active, anti-inflammatory formulations of cannabinoids and terpenes derived from cannabis. In vitro testing on human cell lines and ex vivo testing on inflamed colon biopsies of patients with inflammatory bowel disease has allowed the companies to identify, at the molecular level, synergistic combinations of cannabinoids and terpenes to help reduce inflammation and to potentially improve the quality of life for IBD patients. BB1 Acquisition Corp.
shares V.BBA are trading unchanged at $0.10.
